FCCC LOGO Faculty Publications
Wan B , Lang J , Wang P , Ma CM
Treatment optimization with concurrent SBRT and intracavitary brachytherapy for locally advanced cervical cancer
J Appl Clin Med Phys. 2016 Jan 8;17(1) :70-79
PMID: 26894333    PMCID: PMC5690197    URL: https://www.ncbi.nlm.nih.gov/pubmed/26894333
Back to previous list
Abstract
This work is aimed at investigating treatment planning strategies to optimally com-bine stereotactic body radiation therapy (SBRT) with intracavitary brachytherapy (ICBT) for the treatment of locally advanced cervical cancer. Forty patients (stage IIB - IIIB) previously treated with combined SBRT and ICBT were randomly selected for this retrospective study. All patients were CT- and MR-scanned with a ring applicator in situ. HR-CTV and OARs were contoured according to fused CT and MR images. Several ICBT plans were generated for each patient based on different dose prescription points, and then a matching SBRT plan was generated for each ICBT plan. The dose distribution of each composite plan was analyzed with a focus on the doses received by 90% and 100% of the target volume (D90 and D100), the target volume receiving 100% of the prescription dose (V100%), and the doses received by 2 cc and 40% of the OARs (D2 cc and D40). As the distance, d, between the prescription point and the tandem varied within 1.0 and 1.9 cm, the D90, D100 and V100% for the target, as well as D2 cc and D40 for the bladder and rectum approached their optimal values for d value between 1.0 and 1.4 cm. When design-ing a combined ICBT + SBRT plan, one should measure the size of the cervix and set the prescription isodose line 1.0 to 1.4 cm away from the tandem for the ICBT plan first and then optimize the SBRT plan based on the ICBT dose distribution to achieve the best target coverage and critical structures sparing.
Notes
Wan, Bin Lang, Jinyi Wang, Pei Ma, C-M eng Randomized Controlled Trial J Appl Clin Med Phys. 2016 Jan 8;17(1):70-79. doi: 10.1120/jacmp.v17i1.5610.